Page last updated: 2024-08-23

mefloquine and Common Variable Hypogammaglobulinemia

mefloquine has been researched along with Common Variable Hypogammaglobulinemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chidlow, G; McLean-Tooke, A; Phatouros, CC; Silbert, P; Smith, DW1
Bassetti, CL; Du Pasquier, R; Furrer, H; Hirsch, HH; Kardas, P; Krestel, H; Kurmann, R; Lämmle, B; Sturzenegger, M; Weisstanner, C; Wiest, R1

Other Studies

2 other study(ies) available for mefloquine and Common Variable Hypogammaglobulinemia

ArticleYear
Granule Cell Neuronopathy in a Patient with Common Variable Immunodeficiency.
    Journal of clinical immunology, 2019, Volume: 39, Issue:3

    Topics: Common Variable Immunodeficiency; Female; Humans; JC Virus; Mefloquine; Middle Aged; Mirtazapine; Neurons; Polyomavirus Infections; Treatment Outcome; Virus Activation; Virus Latency

2019
Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
    Journal of neurovirology, 2015, Volume: 21, Issue:6

    Topics: Antiviral Agents; Common Variable Immunodeficiency; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Mianserin; Middle Aged; Mirtazapine; Viremia

2015